Micronoma in the News

Micronoma Breaks Through With Microbiome-BIOTECH: FDA Designation a ‘Milestone’

Feb 8, 2023

Micronoma’s microbiome platform is breaking into its next phase with validation from the U.S. Food and Drug Administration.

Read full article



FDA Grants Novel Liquid Biopsy Assay Breakthrough Device Designation to Detect Lung Cancer

Jan 30, 2023

The FDA has granted breakthrough device designation to the novel, microbiome-driven, liquid biopsy assay OncobiotaLUNG for the detection of lung carcinomas, according to a press release from developer Micronoma.1

Read full article

Micronoma Gets Breakthrough Device Nod for Early Lung Cancer Test

Jan 30, 2023

The FDA has granted Breakthrough Device status to Micronoma’s OncobiotaLUNG microbiome-driven blood assay for early lung cancer detection.

Read full article

FDA Grants Breakthrough Device Designation to OncobiotaLUNG Assay for Lung Cancer Detection

Jan 30, 2023

The FDA has granted the OncobiotaLUNG assay a breakthrough device designation for the early detection of lung cancer.

Read full article


Micronoma Receives FDA Breakthrough Device Designation for OncobiotaLUNG, A Novel Liquid Biopsy Assay for Lung Carcinoma Detection

Jan 30, 2023

Micronoma, the first biotech company offering early cancer detection with a microbiome-driven liquid biopsy platform, announced today that its OncobiotaLUNG assay received the Breakthrough Device Designation from the Food and Drug Administration (FDA).

Read full article

Highs And Lows In The Under 30 World: From A Cancer Screening Breakthrough To A JP Morgan Lawsuit

Jan 30, 2023

Lung cancer is currently the deadliest cancer in the U.S., and unfortunately, even a proper screening for the disease comes with its risks. That’s why Gregory Sepich-Poore, cofounder of Micronoma and an honoree of the Forbes Under 30 2023 Healthcare list, and his team have set out to revolutionize how doctors diagnose lung cancer.

Forbes 30 Under 30 North America 2023 Healthcare

Nov 30, 2022

Forbes has named Micronoma CAO and Co-founder Gregory Sepich-Poore one of its 30 Under 30 in Healthcare for 2023. 

Read full article

Bacteria in tumors may promote cancer

Nov 16, 2022

Microbial interlopers may set off chain reaction that can suppress immune system and lead to metastasis.

Read full article

Translating the Microbiome

Oct 21, 2022

A flurry of microbiome research over the past two decades has led to many insights about the link between the microbes and health, but now the race to the clinic is on. 

Read full article



How Fungi May Open Up New Doors for Cancer Diagnosis, Treatment

Oct 3, 2022

Experts say fungi can be found in a variety of places in the human body as well as in cancer tumors. 

Read full article

Tumor Associated Fungal Signatures May Offer Diagnostic Insights

Oct 3, 2022

Fungal communities (mycobiota) constitute a subset of the human microbiome that can trigger an immune response, but little is known about their presence or functional role in human cancers. 

First-ever mycobiome atlas describes associations between cancers and fungi

Oct 3, 2022

An international team of scientists, co-led by researchers at the University of California San Diego School of Medicine, has created the first pan-cancer mycobiome atlas — a survey of 35 types of cancer and their associated fungi.

Read full article

Fungal DNA, Cells Found in Human Tumors

Sep 30, 2022

Fungal DNA is present in various types of cancer, according to two studies published yesterday (September 29) in Cell.

Read full article



Map of Links between Cancers and Fungi Created

A research team led by the University of California San Diego and the Weizmann Institute of Science in Israel has created an atlas of fungi linked to a range of 35 different cancers for the first time. 

Read full article

A New Approach to Spotting Tumors: Look for Their Microbes

Sep 29, 2022

New research is revealing that cancer is rife with bacteria and fungi – a rich ecosystem that scientists call the tumor microbiome.

Read full article

Leading-Edge Approaches To Early Cancer Detection

Sep 22, 2022

Emerging approaches to the early detection of cancer, based on metabolic profiling and microbiome- and exosome-driven liquid biopsies, were highlighted during the recent Next Generation Dx Summit held in Washington, D.C.

Read full article

Special Report: Life Science, Merging the Biological With the Computational

May 25, 2022

When scientists began mapping of the human genome, the discoveries in our DNA unleashed an era of biology that advanced breakthroughs in diagnostics and biomedicine beyond what was imaginable when the work began. 

Read full article

These innovative projects are changing the health industry

May 3, 2022

The health category of Fast Company’s World Changing Ideas Awards honors medical innovations that save lives, extend longevity, or increase access to care. 

Read full article

Microbiome Therapeutics Try a Lighter Touch

Apr 4, 2022

The revelation that our commensal bacteria play important roles in health and disease has turned the microbiome into one of the most active frontiers of biomedicine. 

Read full article

Could Cancer’s Microbiome Help Diagnose and Treat the Disease?

Mar 14, 2022

As a postdoc at the Broad Institute of MIT and Harvard in 2008, cancer biologist Ravid Straussman worked on a collaborative effort to screen normal cells for their influence on cancer cells’ responses to various anticancer therapies.

Read full article

Precision medicine through the cancer microbiome

Mar 2, 2022

With its Oncobiota platform, Micronoma is pioneering the analysis of the cancer microbiome for early cancer detection and creating tools for personalized cancer treatment.

Read full article 

Female Tech Leaders

Dec 10, 2021

Interview with Sandrine Miller-Montgomery, Micronoma, Inc. 

Read full article

Micronoma, University of New South Wales to Develop Liver Cancer Dx Using $4M Grant

Jul 20, 2021

Microbial cancer detection firm Micronoma said Tuesday that it is collaborating with University of New South Wales.

Read full article

Human Blood Harbors Cell-Free Microbial DNA

Jul 14, 2021

After controlling for high levels of bacterial contamination in their lab and reagents, researchers detect microbial genetic material in plasma samples from healthy people and cancer patients.

Read full article

Micronoma Closes $3.5M Convertible Debt Financing Round

Feb 22, 2021

Micronoma, a San Diego, Calif.-based cancer detection biotech company that utilizes signals from the tumor-related microbiome to diagnose cancer at an early stage with liquid biopsy technology, closed a $3.5m convertible debt financing round.

Read full article

Microbiome-based diagnostics and biomarkers

Feb 2, 2021

Microbiome-based diagnostics and biomarkers: Changing the paradigm in microbiology and medicine.

Read full article

Micronoma Establishes Scientific Advisory Board

Dec 14, 2020

Micronoma, the first cancer detection biotech company that uses signals from the tumor-related microbiome to diagnose cancer at an early stage with minimally-invasive liquid biopsy technology, today announced the formation of its scientific advisory board (SAB).

Read the full article

Micronoma Appoints Magda Marquet to Chairman of the Board

Oct 07 , 2020

 San Diego-based Micronoma, a startup using microbiome analysis for early cancer detection, has appointed Magda Marquet as chairman of the firm’s board. 

 Read the full article

Prime Time for the Microbiome

Sep 28, 2020

Microbiomics is taking a sharp turn. Until now, the field was limited to fecal transplants from healthy patients to those with gut conditions.

Read full article

S.D. biotech lab with ties to UC San Diego works to develop faster cancer detectionMicronoma Establishes Scientific Advisory Board

Sept 04, 2020

A San Diego-based biotech firm that has co-founders from UC San Diego is working to develop and commercialize a minimally invasive method for early cancer detection and recently closed a $3 million seed financing round to further its results. 

Read the full article

Micronoma Launches with $3 Million Seed Funding

Aug 19 , 2020

Micronoma, an early cancer-detection biotech that seeks to develop and commercialize a minimally invasive, microbiome-based method, announced today that it has closed a $3 million seed financing round led by microbiome-focused investor, SymBiosis, LLC. 

 Read the full article

Start-Up Developing Microbial Cancer Detection Tests

Aug 13, 2020

A new company, spun off from university biomedical engineering labs, is creating early cancer diagnostics by analyzing microbial genetics in simple blood samples. 

Read the full article

Micronoma Finds $3M For Early Cancer Detection

Aug 13, 2020

San Diego-based Micronoma, a startup working on early cancer detection, announced this morning that it has raised $3M in a seed financing round.

Read full article

Microbiome analyses of blood and tissues suggest cancer diagnostic approach

Mar 20, 2020

The story behind this paper begins with the loss of my grandmother to pancreatic cancer and the relentless pursuit to understand her disease. 

Read the full article

Microbial Signatures in Blood Are Associated with Various Cancers

Jul 13, 2020

A study suggests the potential for a noninvasive diagnostic that could detect tumors early and differentiate between disease types.

Read full article

Microbial DNA in Patient Blood May be Tell-Tale Sign of Cancer

Mar 11, 2020

From a simple blood draw, microbial DNA may reveal who has cancer and which type, even at early stages

Read full article

Website Terms of Use, Privacy Policy, and Licenses and Accreditations

Micronoma, INC., CLIA #05D2253538

Oncobiota™ LDT is under development and is currently not available for commercial use in any jurisdiction. Once available under CLIA license, Oncobiota™ will be available in the United States by prescription only.

Contact Us

If you have questions or would like to learn more, please email us at info@micronoma.com or learn about joining our team at Careers.

6342 Ferris Square
San Diego, CA 92121